Biotia Provides Microbial Surveillance for Hospitals

On average, one in 25 people who check in to a hospital get an infection— and one in nine die of that infection. Active pathogen surveillance and targeted interventions reduce hospital acquired infections by up to 70%. Current approaches to identify pathogens including culturing and PCR are slow, labor intensive, or inaccurate.

Working across hospitals, we leverage DNA sequencing and artificial intelligent software for affordable active surveillance of high risk units and high risk patients to identify and stop pathogens before patients get sick.

Workflow

  SWAB ENVIRONMENT OR PATIENTS

 SWAB ENVIRONMENT OR PATIENTS

  SEQUENCE DNA

 SEQUENCE DNA

  BIOTIA DATA ANALYSIS

 BIOTIA DATA ANALYSIS

 PROVIDE REPORT

PROVIDE REPORT

Our Team

Biotia was founded by experts in metagenomics, bioinformatics, scientific computing and artificial intelligence, Dr. Niamh B. O'Hara, Dr. Christopher E. Mason, and Dr. Rachid Ounit. We are currently part of a business runway program at Jacobs Technion-Cornell Institute Cornell Tech.

 

Get In Touch

Please contact us with inquiries if you are interested in joining our team or would like to know more about Biotia products.